comparemela.com

Latest Breaking News On - Paperless management solutions for pharmaceutical companies - Page 1 : comparemela.com

Biogen and Eisai revise agreements on Alzheimer s disease therapies

Biogen and Eisai have revised their current partnership agreements on Alzheimer's disease (AD) therapies, aducanumab and lecanemab.

Haruo naitoPaperless management solutions for pharmaceutical companiesAseptic process solutions for the pharmaceutical industryDrug administrationPharmaceutical technologyCell culture mediaManufactured quaternary ammoniumProcess solutionsManagement solutions

Covid-19 update: Cough drop sales could track Omicron spread

The global Covid death toll has passed 6 million, with a figure of 6,022,223 according to researchers at Johns Hopkins University.

South africaUnited kingdomNew zealandSouth africansRosa delauroOng ye kungAlex cookBenjamin netanyahuAnders tegnellJohns hopkins universityMalaysia airlinesNational health commissionWorld health organizationMinistry of healthImperial collegeHealth ministry

Quoin expands distribution deal with ER-Kim for Netherton Syndrome

Quoin and ER-Kim have expanded their distribution agreement for the former’s investigational therapy, QRX003, to treat Netherton Syndrome.

United statesCzech republicMichael myersPaperless management solutions for pharmaceutical companiesAnalytical services for biological assaysQuoin pharmaceuticalsNetherton syndromeKazal typeNorth macedoniaPharmaceutical technologyHandling productsTurnkey process systemsManagement solutions

Pfizer and BioNTech seek FDA EUA for Covid-19 vaccine use in children

Pfizer and BioNTech have commenced a rolling submission seeking modification of EUA for their Covid-19 vaccine to include children.

Biontech covidAlbert bourlaPaperless management solutions for pharmaceutical companiesEuropean medicines agencyDrug administrationProducts advisory committeeEmergency use authorizationRelated biological products advisory committeePharmaceutical technologyManagement solutionsSeparation solutionsPurifying active pharmaceutical

vimarsana © 2020. All Rights Reserved.